🇺🇸 Ethinylestradiol / Norethisterone in United States
114 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 114
Most-reported reactions
- Nausea — 16 reports (14.04%)
- Pain — 15 reports (13.16%)
- Fatigue — 12 reports (10.53%)
- Anxiety — 11 reports (9.65%)
- Dizziness — 11 reports (9.65%)
- Cough — 10 reports (8.77%)
- Diarrhoea — 10 reports (8.77%)
- Dyspnoea — 10 reports (8.77%)
- Headache — 10 reports (8.77%)
- Deep Vein Thrombosis — 9 reports (7.89%)
Other Contraception / Reproductive Health approved in United States
Frequently asked questions
Is Ethinylestradiol / Norethisterone approved in United States?
Ethinylestradiol / Norethisterone does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Ethinylestradiol / Norethisterone in United States?
University of Edinburgh is the originator. The local marketing authorisation holder may differ — check the official source linked above.